1. Home
  2. RGEN vs FIGR Comparison

RGEN vs FIGR Comparison

Compare RGEN & FIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FIGR
  • Stock Information
  • Founded
  • RGEN 1981
  • FIGR 2018
  • Country
  • RGEN United States
  • FIGR United States
  • Employees
  • RGEN N/A
  • FIGR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FIGR Finance: Consumer Services
  • Sector
  • RGEN Health Care
  • FIGR Finance
  • Exchange
  • RGEN Nasdaq
  • FIGR Nasdaq
  • Market Cap
  • RGEN 6.5B
  • FIGR 6.9B
  • IPO Year
  • RGEN N/A
  • FIGR 2025
  • Fundamental
  • Price
  • RGEN $145.83
  • FIGR $43.96
  • Analyst Decision
  • RGEN Buy
  • FIGR Buy
  • Analyst Count
  • RGEN 11
  • FIGR 8
  • Target Price
  • RGEN $167.90
  • FIGR $46.69
  • AVG Volume (30 Days)
  • RGEN 929.7K
  • FIGR 7.1M
  • Earning Date
  • RGEN 11-11-2025
  • FIGR 01-01-0001
  • Dividend Yield
  • RGEN N/A
  • FIGR N/A
  • EPS Growth
  • RGEN N/A
  • FIGR N/A
  • EPS
  • RGEN N/A
  • FIGR 1.25
  • Revenue
  • RGEN $673,956,000.00
  • FIGR $327,242,000.00
  • Revenue This Year
  • RGEN $16.77
  • FIGR N/A
  • Revenue Next Year
  • RGEN $13.79
  • FIGR N/A
  • P/E Ratio
  • RGEN N/A
  • FIGR $35.38
  • Revenue Growth
  • RGEN 8.73
  • FIGR 81.34
  • 52 Week Low
  • RGEN $102.97
  • FIGR $30.01
  • 52 Week High
  • RGEN $182.52
  • FIGR $49.45
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 68.33
  • FIGR N/A
  • Support Level
  • RGEN $121.25
  • FIGR N/A
  • Resistance Level
  • RGEN $125.90
  • FIGR N/A
  • Average True Range (ATR)
  • RGEN 5.31
  • FIGR 0.00
  • MACD
  • RGEN 2.79
  • FIGR 0.00
  • Stochastic Oscillator
  • RGEN 84.15
  • FIGR 0.00

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: